Newborn affected by maternal use of sedative-hypnotics
ICD-10 P04.17 is a billable code used to indicate a diagnosis of newborn affected by maternal use of sedative-hypnotics.
P04.17 refers to newborns who are affected by the maternal use of sedative-hypnotics during pregnancy. This condition arises when substances such as benzodiazepines or barbiturates are used by the mother, leading to potential withdrawal symptoms or other complications in the newborn. The impact of sedative-hypnotics can manifest as respiratory depression, lethargy, feeding difficulties, and altered neurological status. The severity of symptoms can vary based on the timing and dosage of maternal drug use, as well as the specific substances involved. Newborns may require close monitoring in a neonatal intensive care unit (NICU) for signs of withdrawal or other complications. It is crucial for healthcare providers to document maternal substance use thoroughly, as this information is vital for appropriate management and coding. The condition underscores the importance of prenatal care and the need for healthcare providers to counsel expectant mothers about the risks associated with drug use during pregnancy.
Detailed maternal history, including specific substances used, timing, and dosage.
Newborns presenting with lethargy, respiratory distress, or feeding difficulties in the NICU.
Monitoring for withdrawal symptoms and ensuring accurate coding based on clinical presentation.
Documentation of developmental assessments and follow-up care for affected newborns.
Pediatric evaluations of newborns with a history of maternal sedative-hypnotic use.
Consideration of long-term developmental impacts and the need for multidisciplinary follow-up.
Used for initial assessment of a newborn affected by maternal sedative-hypnotics.
Document maternal drug history and newborn assessment findings.
Neonatologists should ensure comprehensive evaluations are performed.
Common symptoms include lethargy, respiratory depression, feeding difficulties, and irritability. Monitoring in a NICU setting is often required for these newborns.
